Do patients with recurrent episodes of campylobacteriosis differ from those with a single disease event?

Arsenault, Julie; Ravel, André; Michel, Pascal; Berke, Olaf; Gosselin, Pierre
January 2011
BMC Public Health;2011, Vol. 11 Issue 1, p1
Academic Journal
Background: Although Campylobacter is the leading cause of reported bacterial gastro-enteritis in industrialized countries, little is known on its recurrence. The objective of this study is to describe the risk and the patient characteristics of recurrent episodes of human campylobacteriosis reported in Quebec. Methods: Laboratory-confirmed cases of campylobacteriosis reported in the province of Quebec, Canada, through ongoing surveillance between 1996 and 2006 were analyzed. The risk of having a recurrent episode of campylobacteriosis was described using life table estimates. Logistic regression was used to assess if gender, age and patient residential location were associated with an increased risk of recurrence. Results: Compared to the baseline risk, the risk for a recurrent disease event was higher for a period of four years and followed a decreasing trend. This increased risk of a recurrent event was similar across gender, but higher for people from rural areas and lower for children under four years of age. Conclusions: These results may suggest the absence of durable immunity or clinical resilience following a first episode of campylobacteriosis and periodical re-exposure, at least among cases reported through the surveillance system.


Related Articles

  • Geographic determinants of reported human Campylobacter infections in Scotland. Bessell, Paul R.; Matthews, Louise; Smith-Palmer, Alison; Rotariu, Ovidiu; Strachan, Norval J. C.; Forbes, Ken J.; Cowden, John M.; Reid, Stuart W. J.; Innocent, Giles T. // BMC Public Health;2010, Vol. 10 Issue 1, p423 

    Background: Campylobacteriosis is the leading cause of bacterial gastroenteritis in most developed countries. People are exposed to infection from contaminated food and environmental sources. However, the translation of these exposures into infection in the human population remains incompletely...

  • Gastroenteritis from a non-chlorinated water supply.  // Occupational & Environmental Medicine;Jun2004, Vol. 61 Issue 6, p517 

    Provides information on an outbreak of gastroenteritis caused by campylobacter infection in Finland in August 2000. Risk factors of campylobacter infection; Examples of protective drinking water; Cause of the outbreak.

  • Gastroenterite Aguda por Campylobacter Spp: Casuística de uma Urgência Pediátrica. SOARES, Ana Teresa; COUTO, Catarina; ROMÃO, Patrícia; MELO, Isabel Saraiva de; BRAGA, Manuela; DIOGO, José; CALHAU, Paulo // Acta Medica Portuguesa;set/out2014, Vol. 27 Issue 5, p556 

    Introduction: Infection by Cambylobacter occurs worldwide and represents the main cause of acute bacterial gastroenteritis within the European Union. Aims: Determine the prevalence of Campylobacter in stool cultures from patients with gastroenteritis and study their microbiological,...

  • Human Campylobacteriosis in Developing Countries. Coker, Akitoye O.; Isokpehi, Raphael D.; Thomas, Bolaji N.; Amisu, Kehinde O.; Obi, C. Larry // Emerging Infectious Diseases;Mar2002, Vol. 8 Issue 3, p237 

    Presents a study which analyzed the distinguishing features of human campylobacteriosis in developing countries relative to developed countries. Estimates of incidence in developing countries; Discussion on polymicrobial infections involving campylobacter; Isolation of campylobacter in healthy...

  • Arcobacter butzleri: Underestimated Enteropathogen. Prouzet-Mauléon, Valérie; Labadi, Leila; Bouges, Nathalie; Ménard, Armelle; Mégraud, Francis // Emerging Infectious Diseases;Feb2006, Vol. 12 Issue 2, p307 

    Molecular methods applied to 2,855 strains of Campylobacter-like organisms received from a surveillance network of Campylobacter infections in France identified 29 Arcobacter butzleri infections. This species ranks fourth for Campylobacteraceae isolation and appears to have the same pathogenic...

  • The spatial distribution of campylobacteriosis in New Zealand, 1997-2005. RIND, E.; PEARCE, J. // Epidemiology & Infection;Oct2010, Vol. 138 Issue 10, p1359 

    In New Zealand Campylobacter infection rates have increased steadily since 1980, reaching a peak in 2003 (396/100 000 population). Compared to other nations, disease rates are unfavourably high (e.g. Australia 117/100 000 population, UK 85/100 000 population, USA 13/100 000 population). This...

  • Regional risks and seasonality in travel-associated campylobacteriosis. Ekdahl, Karl; Andersson, Yvonne // BMC Infectious Diseases;2004, Vol. 4 Issue 1, p54 

    Background: The epidemiology of travel-associated campylobacteriosis is still largely unclear, and various known risk factors could only explain limited proportions of the recorded cases. Methods: Using data from 28,704 notifications of travel-associated campylobacteriosis in Sweden 1997 to 2003...

  • Domestically Acquired Campylobacter Infections in Finland. Vierikko, Antti; Hänninen, Marja-Liisa; Siitonen, Anja; Ruutu, Petri; Rautelin, Hilpi // Emerging Infectious Diseases;Jan2004, Vol. 10 Issue 1, p127 

    Campylobacter jejuni isolates (n = 533) from domestic cases diagnosed in Finland during a 3-month peak period were studied. The highest rate was observed among those 70-74 years of age. Domestic C. jejuni isolates were especially frequent in the eastern districts. Six serotypes covered 61% of...

  • Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Tribble, David R.; Baqar, Shahida; Carmolli, Marya P.; Porter, Chad; Pierce, Kristen K.; Sadigh, Katrin; Guerry, Patricia; Larsson, Catherine J.; Rockabrand, David; Ventone, Cassandra H.; Frederic Poly; Lyon, Caroline E.; Dakdouk, Sandra; Fingar, Ann; Gilliland Jr., Theron; Daunais, Patrick; Jones, Erika; Rymarchyk, Stacia; Huston, Christopher; Darsley, Michael // Clinical Infectious Diseases;11/15/2009, Vol. 49 Issue 10, p1512 

    Background. A robust human challenge model for Campylobacter jejuni is an important tool for the evaluation of candidate vaccines. The previously established model conveys a potential risk of Guillain-Barre syndrome attributable to lipooligosaccharide ganglioside mimicry. This work establishes a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics